Reuters UK Business

By Jesús Aguado and Saeed Azhar MADRID/NEW YORK (Reuters) – Spain’s Santander launched its digital bank in the United States on Monday, which will help it to fund over $30 billion of auto lending assets and broaden its retail business in the country, U.S. CEO Tim Wennes told Reuters. The euro zone’s third-biggest lender by …

Santander launches digital bank in US to gain cheaper funding for auto loans Read More »

(Reuters) -Jeff Bezos-backed Perplexity AI has begun fundraising talks in which it is looking to more than double its valuation to $8 billion or more, the Wall Street Journal reported on Sunday. Perplexity has told investors it is looking to raise around $500 million in the new funding round, the Journal reported citing people familiar …

Perplexity AI in funding talks to more than double valuation to $8 billion, WSJ reports Read More »

ZURICH (Reuters) -UBS is offloading part of the Credit Suisse business it acquired last year with a deal to sell the fallen bank’s 50% stake in credit card provider Swisscard. UBS will sell its 50% holding in the company to its joint venture partner American Express, Swisscard said in a statement. Terms of the deal …

UBS sells its 50% stake in Swisscard to American Express Read More »

By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). French public investment bank Bpifrance is expected to become a minority shareholder, taking a stake of around …

Sanofi in exclusive talks with CD&R over sale of $17 billion Opella Read More »

(Reuters) – Novo Nordisk said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular events in patients in a late-stage study. The drug, Rybelsus, helped reduce the risk of these events, including cardiovascular death, non-fatal heart attack and stroke, by 14% compared to placebo, meeting the main goal …

Novo Nordisk’s oral diabetes drug cuts heart-related risks by 14% in study Read More »

PARIS (Reuters) -French supermarket retailer Carrefour said on Monday it is reviewing how staff are treated at Majid Al Futtaim (MAF), its Saudi Arabia franchise partner, after Amnesty International raised concerns over employees’ working conditions. A report by Amnesty International, published on Monday, said some staff working at the Carrefour/Majid Al Futtaim stores in Saudi …

Retailer Carrefour reviewing work practices at Saudi partner after Amnesty raises concerns Read More »

By Marie Mannes STOCKHOLM (Reuters) – Swedish battery maker Northvolt is making significant progress towards raising a new financing package, it told Reuters on Monday. The group has been in talks with investors and lenders in recent weeks to secure short-term funding, three sources familiar with the matter told Reuters on Oct. 11, as the …

Northvolt making progress towards securing financing package Read More »